The Florida Department of Health notified the FDA of a cluster of streptococcus endophthalmitis infections in three clinics, following intravitreal injection of the repackaged Avastin.
The tainted injections were traced to a pharmacy in Hollywood, Fla.
Related Articles on FDA Alerts:
FDA Warns Healthcare Professionals to Stop Using Claris IV Bags
Hospira Expands Recall of Propofol and Liposyn
Commentary on Safety Concerns Regarding Fresenius Propofol From Anesthesiologist Daniel Van Riper
